Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized three-arm blinded study of Solcera versus placebo with investigator-blinded Solaraze comparison in actinic keratosis
2019-003678-16Phase 3Completed
- Sponsor
- InfectoPharm
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in actinic keratosis (AK) (3 arms), sponsored by InfectoPharm. Primary endpoint: Therapy success at end of treatment. Started Mar 2020; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2019-003678-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003678-16.